Peringkat dalam Saham
#33058
Arctic Bioscience AS, a clinical-stage biotechnology company, engages in... Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific. The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis. It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand name. Arctic Bioscience AS was incorporated in 2011 and is headquartered in Ørsta, Norway.
Kapitalisasi Pasar
$8.48M
Perubahan (1 tahun)
-2.55%
Perdagangan Arctic Bioscience AS (ABS)
Harga ABS dengan kapitalisasi pasar B
Kapitalisasi pasar dari Arctic Bioscience AS(ABS)
Kapitalisasi Pasar: $8.48M
Per August 2026, Arctic Bioscience AS memiliki kapitalisasi pasar sebesar $8.48M. Ini menjadikan Arctic Bioscience AS sebagai perusahaan 33058th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Arctic Bioscience AS dari 2021 hingga 2026
ABS dibandingkan dengan 5 teratas stocks paling populer
| Harga ABS |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.470T
|
+64,527,931.12%
|
|
|
|
|
$4.504T
|
+53,133,148.54%
|
|
|
|
|
$4.169T
|
+49,186,106.60%
|
|
|
|
|
$3.616T
|
+42,662,037.54%
|
|
|
|
|
$2.829T
|
+33,373,986.80%
|
